Effects of pentoxifylline treatment on delayed graft function in cadaveric kidney recipients

Transplantation Proceedings

Volumn 32, Issue 6, 2000, Pages 1382-1383

  Wlodarczyk, Z ^a   Oko, A ^b   Glyda, M ^a   Karczewski, M ^a   Idasiak Piechocka, I ^b   Czekalski, S ^b  

^a District Hospital   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

PENTOXIFYLLINE;

ADULT; CADAVER KIDNEY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GRAFT SURVIVAL; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; URINARY EXCRETION;

ADULT; BIOLOGICAL MARKERS; CADAVER; COMPARATIVE STUDY; ENDOTHELINS; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; MALE; PENTOXIFYLLINE; PLACEBOS; PROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; THROMBOXANE B2; TISSUE DONORS; TUMOR NECROSIS FACTOR; VASODILATOR AGENTS;

EID: 0033829259     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)01266-5     Document Type: Conference Paper

References (11)

1. Sinzinger H. Prostaglandins Leukot Med. 12:1983;217.
2. Bilto Y.Y., Ellory J.C., Player M., et al. Clin Hemorheol. 8:1988;901.
3. Luke DR, Berens KL, Verani RR: Ren Fail 11:187, 1989-1990.
4. Han J., Thompson P., Beutler B. J Exp Med. 172:1990;391.
5. Carrier M., Perrault L.P., Tronc F., et al. Ann Thorac Surg. 55:1993;490.
6. Berens K.L., Luke D.R. Transplantation. 49:1990;876.
7. Oko A., Krzymański M., Waaga A.M., et al. Ann Acad Med Gedan. 25:(suppl 6):1995;213.
8. Noel C., Hazzan M., Coppin M.C., et al. Clin Transplant. 11:1997;169.
9. Königsrainer A., Aichberger C., Riedman B., et al. Transplant Proc. 27:1995;1062.
10. Frantz R.P., Brooks S.E., Olson L.J., et al. Transplantation. 63:1997;1607.
11. Noel C., Hazzan M., Labalette M., et al. Transplantation. 65:1998;385.